Lilly Invests $6 Billion on New Alabama Drug Manufacturing Site
Lilly is investing $6 billion to build a new drug-ingredient manufacturing plant in Huntsville, Alabama, part of a push to shore up U.S. pharmaceutical supply chains.
Lilly is investing $6 billion to build a new drug-ingredient manufacturing plant in Huntsville, Alabama, part of a push to shore up U.S. pharmaceutical supply chains.